Formula optimization of Rifampicin dry powder inhalation with chitosan-xanthan carrier using response surface methodology

Research output: Contribution to journalArticlepeer-review

4 Citations (Scopus)

Abstract

This study was aimed to obtain an optimum formula of rifampicin dry powder inhalation (DPI) with chitosan-xanthan (CX) as a carrier by spray drying method using response surface methodology (RSM). Fourteen experimental formulas were designed statistically by Box Behnken method by varying three parameters namely concentration of CX solution, rifampicin/CX ratio, and inlet temperature of the spray dryer. The entrapment efficiency (EE), particle size, and drug release in pH 7.4 (pulmonary condition) and pH 4.5 (pulmonary macrophages condition) of the rifampicin DPI were characterized. The optimum formula of rifampicin DPI was obtained using Design Expert software. The obtained DPI from those 14 formulas possessed EE of 112.00-149.08% and average particle sizes of 0.599-5.506 μm. Rifampicin release in phosphate buffer medium pH 7.4 was 6.54%-22.95% and in pH 4.5 was 12.02-48.60%. The Design Expert predicted that the optimum formula would be obtained with a concentration of CX solution of 0.5%, a ratio of rifampicin to CX 1:1, and inlet temperature of the spray dryer at 143°C. The optimized formula produced a rifampicin DPI with EE of 108.9%, the particle size of 1.177 μm, and the rifampicin release of 14.49% (at pH 7.4) and of 37.97% (at pH 4.5).

Original languageEnglish
Pages (from-to)33-41
Number of pages9
JournalJournal of Applied Pharmaceutical Science
Volume9
Issue number1
DOIs
Publication statusPublished - 1 Jan 2019

Keywords

  • Chitosan-xanthan
  • Dry powder inhalation
  • Response surface methodology
  • Rifampicin
  • Spray drying

Fingerprint

Dive into the research topics of 'Formula optimization of Rifampicin dry powder inhalation with chitosan-xanthan carrier using response surface methodology'. Together they form a unique fingerprint.

Cite this